BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 26264613)

  • 21. Expression of the sodium iodide symporter and thyroglobulin genes are reduced in papillary thyroid cancer.
    Ringel MD; Anderson J; Souza SL; Burch HB; Tambascia M; Shriver CD; Tuttle RM
    Mod Pathol; 2001 Apr; 14(4):289-96. PubMed ID: 11301345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NADPH Oxidase NOX4 Is a Critical Mediator of BRAF
    Azouzi N; Cailloux J; Cazarin JM; Knauf JA; Cracchiolo J; Al Ghuzlan A; Hartl D; Polak M; Carré A; El Mzibri M; Filali-Maltouf A; Al Bouzidi A; Schlumberger M; Fagin JA; Ameziane-El-Hassani R; Dupuy C
    Antioxid Redox Signal; 2017 May; 26(15):864-877. PubMed ID: 27401113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TGFB1-driven mesenchymal stem cell-mediated NIS gene transfer.
    Schug C; Urnauer S; Jaeckel C; Schmohl KA; Tutter M; Steiger K; Schwenk N; Schwaiger M; Wagner E; Nelson PJ; Spitzweg C
    Endocr Relat Cancer; 2019 Jan; 26(1):89-101. PubMed ID: 30121623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transforming growth factor-beta1 and activin A generate antiproliferative signaling in thyroid cancer cells.
    Matsuo SE; Leoni SG; Colquhoun A; Kimura ET
    J Endocrinol; 2006 Jul; 190(1):141-50. PubMed ID: 16837618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long non-coding RNA ANRIL promotes the invasion and metastasis of thyroid cancer cells through TGF-β/Smad signaling pathway.
    Zhao JJ; Hao S; Wang LL; Hu CY; Zhang S; Guo LJ; Zhang G; Gao B; Jiang Y; Tian WG; Luo DL
    Oncotarget; 2016 Sep; 7(36):57903-57918. PubMed ID: 27507052
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of low sodium-iodide symporter messenger ribonucleic acid expression in malignant thyroid nodules with increased intracellular protein staining.
    Sodré AK; Rubio IG; Galrão AL; Knobel M; Tomimori EK; Alves VA; Kanamura CT; Buchpiguel CA; Watanabe T; Friguglietti CU; Kulcsar MA; Medeiros-Neto G; Camargo RY
    J Clin Endocrinol Metab; 2008 Oct; 93(10):4141-5. PubMed ID: 18628528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reintroducing the Sodium-Iodide Symporter to Anaplastic Thyroid Carcinoma.
    Schmohl KA; Dolp P; Schug C; Knoop K; Klutz K; Schwenk N; Bartenstein P; Nelson PJ; Ogris M; Wagner E; Spitzweg C
    Thyroid; 2017 Dec; 27(12):1534-1543. PubMed ID: 29032724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low expression of sodium iodide symporter expression in aggressive variants of papillary thyroid carcinoma.
    Wei S; Gao M; Zhao C; Pan Y; Li H; Li J; Li X
    Int J Clin Oncol; 2014 Oct; 19(5):800-4. PubMed ID: 24096868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene expression profile analyze the molecular mechanism of CXCR7 regulating papillary thyroid carcinoma growth and metastasis.
    Zhang H; Teng X; Liu Z; Zhang L; Liu Z
    J Exp Clin Cancer Res; 2015 Feb; 34(1):16. PubMed ID: 25887589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of transforming growth factor-beta1 and transforming growth factor-beta Type-II receptor mRNA in papillary thyroid carcinoma.
    Matoba H; Sugano S; Yamaguchi N; Miyachi Y
    Horm Metab Res; 1998 Oct; 30(10):624-8. PubMed ID: 9851670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The correlation of sodium iodide symporter and BRAF(V600E) mutation in classical variant papillary thyroid carcinoma.
    Yazgan A; Yıldırım N; Gözalan A; Gümüştaş S; Kılıçarslan A; Balci S; Aydın C; Ersoy R; Cakir B; Güler G
    Ann Diagn Pathol; 2016 Jun; 22():58-62. PubMed ID: 27180062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BRAFV600E mutation, but not RET/PTC rearrangements, is correlated with a lower expression of both thyroperoxidase and sodium iodide symporter genes in papillary thyroid cancer.
    Romei C; Ciampi R; Faviana P; Agate L; Molinaro E; Bottici V; Basolo F; Miccoli P; Pacini F; Pinchera A; Elisei R
    Endocr Relat Cancer; 2008 Jun; 15(2):511-20. PubMed ID: 18509003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FoxP3 expression in papillary thyroid carcinoma: a possible resistance biomarker to iodine 131 treatment.
    Ugolini C; Elisei R; Proietti A; Pelliccioni S; Lupi C; Borrelli N; Viola D; Leocata P; Vitti P; Miccoli P; Toniolo A; Basolo F
    Thyroid; 2014 Feb; 24(2):339-46. PubMed ID: 23915122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. mTOR Pathway in Papillary Thyroid Carcinoma: Different Contributions of mTORC1 and mTORC2 Complexes for Tumor Behavior and
    Tavares C; Eloy C; Melo M; Gaspar da Rocha A; Pestana A; Batista R; Bueno Ferreira L; Rios E; Sobrinho Simões M; Soares P
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29757257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential expression of transforming growth factor-beta in benign vs. papillary thyroid cancer nodules; a potential diagnostic tool?
    Brace MD; Wang J; Petten M; Bullock MJ; Makki F; Trites J; Taylor SM; Hart RD
    J Otolaryngol Head Neck Surg; 2014 Jul; 43(1):22. PubMed ID: 25927212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expressions of human sodium iodide symporter mRNA in primary and metastatic papillary thyroid carcinomas.
    Park HJ; Kim JY; Park KY; Gong G; Hong SJ; Ahn IM
    Thyroid; 2000 Mar; 10(3):211-7. PubMed ID: 10779135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutual regulation of TGF-β1, TβRII and ErbB receptors expression in human thyroid carcinomas.
    Mincione G; Tarantelli C; Vianale G; Di Marcantonio MC; Cotellese R; Francomano F; Di Nicola M; Costantini E; Cichella A; Muraro R
    Exp Cell Res; 2014 Sep; 327(1):24-36. PubMed ID: 24973511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of all-trans retinoic acid on sodium/iodide symporter expression, radioiodine uptake and gene expression profiles in a human anaplastic thyroid carcinoma cell line.
    Jeong H; Kim YR; Kim KN; Choe JG; Chung JK; Kim MK
    Nucl Med Biol; 2006 Oct; 33(7):875-82. PubMed ID: 17045167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-21 negatively regulates Treg cells through a TGF-β1/Smad-independent pathway in patients with coronary heart disease.
    Li S; Fan Q; He S; Tang T; Liao Y; Xie J
    Cell Physiol Biochem; 2015; 37(3):866-78. PubMed ID: 26383248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reciprocal immunohistochemical expression of sodium/iodide symporter and hexokinase I in primary thyroid tumors with synchronous cervical metastasis.
    Jung YH; Hah JH; Sung MW; Kim KH; Cho SY; Jeon YK
    Laryngoscope; 2009 Mar; 119(3):541-8. PubMed ID: 19235753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.